Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Perrone

Showing results (71-80 of 184) with videos related to

Pageof 19
Sort By:
Tumori|December 31, 1991
Salvage chemotherapy with CCNU and methotrexate for small cell lung cancer resistant to CAV/PE alternating chemotherapyC Gridelli, A Contegiacomo, R Lauria, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
Phase II study of intensive CEV (carboplatin, epirubicin and VP-16) plus G-CSF (granulocyte-colony stimulating factor) in extensive small cell lung cancerC Gridelli, F Perrone, M D'Aprile, et al.
Tumori|December 31, 1990
Expression of two antigens defined by monoclonal antibodies in normal, benign and malignant human mammary tissuesF Perrone, S Ménard, M G Da Dalt, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 15, 2001
Rb and TP53 pathway alterations in sporadic and NF1-related malignant peripheral nerve sheath tumorsS Birindelli, F Perrone, M Oggionni, et al.
American Journal of Human Genetics|March 28, 2003
Elevated risk for MPNST in NF1 microdeletion patientsT De Raedt, H Brems, P Wolkenstein, et al.
Cancer|October 3, 2000
Intermediate dose recombinant interferon-alpha as second-line treatment for patients with recurrent cutaneous melanoma who were pretreated with low dose interferonP A Ascierto, A Daponte, R Parasole, et al.
Oncology|July 1, 1995
Prognostic significance of necrosis, elastosis, fibrosis and inflammatory cell reaction in operable breast cancerC Carlomagno, F Perrone, R Lauria, et al.
Cancer|November 15, 1995
The prognostic value of lymphatic and blood vessel invasion in operable breast cancerR Lauria, F Perrone, C Carlomagno, et al.
British Journal of Cancer|March 1, 1992
Study of the biological and prognostic significance of the antigen CaMBr8 on breast carcinomaP Facheris, F Perrone, S Ménard, et al.
ESMO Open|July 27, 2024
Association between health-related quality-of-life results, outcomes of efficacy and drug approvals: a meta-research study of randomized phase III trials in oncologyC Paratore, C Zichi, R Schiavone, et al.
Pageof 19

Showing results (71-80 of 184) with videos related to

Sort By:
Pageof 19
Tumori|December 31, 1991
Salvage chemotherapy with CCNU and methotrexate for small cell lung cancer resistant to CAV/PE alternating chemotherapyC Gridelli, A Contegiacomo, R Lauria, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
Phase II study of intensive CEV (carboplatin, epirubicin and VP-16) plus G-CSF (granulocyte-colony stimulating factor) in extensive small cell lung cancerC Gridelli, F Perrone, M D'Aprile, et al.
Tumori|December 31, 1990
Expression of two antigens defined by monoclonal antibodies in normal, benign and malignant human mammary tissuesF Perrone, S Ménard, M G Da Dalt, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 15, 2001
Rb and TP53 pathway alterations in sporadic and NF1-related malignant peripheral nerve sheath tumorsS Birindelli, F Perrone, M Oggionni, et al.
American Journal of Human Genetics|March 28, 2003
Elevated risk for MPNST in NF1 microdeletion patientsT De Raedt, H Brems, P Wolkenstein, et al.
Cancer|October 3, 2000
Intermediate dose recombinant interferon-alpha as second-line treatment for patients with recurrent cutaneous melanoma who were pretreated with low dose interferonP A Ascierto, A Daponte, R Parasole, et al.
Oncology|July 1, 1995
Prognostic significance of necrosis, elastosis, fibrosis and inflammatory cell reaction in operable breast cancerC Carlomagno, F Perrone, R Lauria, et al.
Cancer|November 15, 1995
The prognostic value of lymphatic and blood vessel invasion in operable breast cancerR Lauria, F Perrone, C Carlomagno, et al.
British Journal of Cancer|March 1, 1992
Study of the biological and prognostic significance of the antigen CaMBr8 on breast carcinomaP Facheris, F Perrone, S Ménard, et al.
ESMO Open|July 27, 2024
Association between health-related quality-of-life results, outcomes of efficacy and drug approvals: a meta-research study of randomized phase III trials in oncologyC Paratore, C Zichi, R Schiavone, et al.
Pageof 19